Your browser doesn't support javascript.
loading
Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial.
Leere, Julius Simoni; Karmisholt, Jesper; Robaczyk, Maciej; Lykkeboe, Simon; Handberg, Aase; Steinkohl, Emilie; Brøndum Frøkjær, Jens; Vestergaard, Peter.
Afiliação
  • Leere JS; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. Electronic address: j.leere@rn.dk.
  • Karmisholt J; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; Department of Endocrinology, Aalborg University, Aalborg, Denmark.
  • Robaczyk M; Department of Endocrinology, Aalborg University, Aalborg, Denmark.
  • Lykkeboe S; Department of Clinical Biochemistry, Aalborg University, Aalborg, Denmark.
  • Handberg A; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; Department of Clinical Biochemistry, Aalborg University, Aalborg, Denmark.
  • Steinkohl E; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; Department of Radiology, Aalborg University, Aalborg, Denmark.
  • Brøndum Frøkjær J; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; Department of Radiology, Aalborg University, Aalborg, Denmark.
  • Vestergaard P; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; Department of Endocrinology, Aalborg University, Aalborg, Denmark; Steno Diabetes Center North Jutland, Aalborg, Denmark.
Lancet Diabetes Endocrinol ; 8(5): 407-417, 2020 05.
Article em En | MEDLINE | ID: mdl-32333877
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperparatireoidismo Primário / Cinacalcete / Denosumab Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Diabetes Endocrinol Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperparatireoidismo Primário / Cinacalcete / Denosumab Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Diabetes Endocrinol Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido